Search Results - Farrell, Annamaria

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    676 - Dupilumab increases levels of bone growth biomarker irrespective of prior use of systemic corticosteroids in children with moderate-to-severe atopic dermatitis

    676 - Dupilumab increases levels of bone growth biomarker irrespective of prior use of systemic corticosteroids in children with moderate-to-severe atopic dermatitis by Irvine, Alan D, Paller, Amy S, Hamon, Sara, Horowitz, Julie, Farrell, Annamaria, Hatsell, Sarah, Ehmann, Peter, Marco, Ainara Rodríguez, Bansal, Ashish, Chen, Zhen, Levy, Stephane, Cyr, Sonya L

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P93 Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers

    P93 Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers by Irvine, Alan D, Paller, Amy S, Horowitz, Julie E, Farrell, Annamaria, Hatsell, Sarah, Ehmann, Peter, McDonald, Robert, Marco, Ainara Rodriguez, Tian, Tingting, Cyr, Sonya L

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    340 Dupilumab treatment of children with moderate-to-severe atopic dermatitis increases bone alkaline phosphatase, a marker of bone mineralization

    340 Dupilumab treatment of children with moderate-to-severe atopic dermatitis increases bone alkaline phosphatase, a marker of bone mineralization by Irvine, Alan D, Paller, Amy S, Hamon, Sara, Horowitz, Julie, Farrell, Annamaria, Hatsell, Sarah, Marco, Ainara Rodríguez, Bansal, Ashish, Chen, Zhen, Cyr, Sonya L

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Characterization and Management of Oral and Dermatological Toxicities in Patients Receiving the CD3 X GPRC5D Bispecific Antibody Talquetamab (JNJ-64407564) for the Treatment of Relapsed and/or Refractory Multiple Myeloma

    Characterization and Management of Oral and Dermatological Toxicities in Patients Receiving the CD3 X GPRC5D Bispecific Antibody Talquetamab (JNJ-64407564) for the Treatment of Rel... by Mancia, Stefania Stefania, Farrell, Annamaria, Louw, Karen, Florendo, Erika, Aronson, Elizabeth, Purcell, Kiah, Catamero, Donna D, Escalon, Juliet, Thomas, Joanne, Aponte, Annel, Lamb, Angela, Kirke, Diana, Lucas, Aimee, Jagannath, Sundar, Cho, Hearn Jay, Parekh, Samir, Richter, Joshua, Sanchez, Larysa, Chari, Ajai

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Innovative approaches to service integration addressing the unmet needs of irritable bowel syndrome patients and new approaches for the needs of IBS patients

    Innovative approaches to service integration addressing the unmet needs of irritable bowel syndrome patients and new approaches for the needs of IBS patients by Gentile, Maurizio, De Luca, Vincenzo, Patalano, Roberta, Laudisio, Daniela, Tramontano, Giovanni, Lindner-Rabl, Sonja, Mercurio, Lorenzo, Salvatore, Elena, Farrell, John, Roller-Wirnsberger, Regina, Kubitschke, Lutz, Triassi, Maria, Colao, Annamaria, Illario, Maddalena

    Published in Frontiers in medicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: